Related references
Note: Only part of the references are listed.Tumor penetrating peptides inhibiting MYC as a potent targeted therapeutic strategy for triple-negative breast cancers
Edina Wang et al.
ONCOGENE (2019)
PD-1 pathway and its clinical application: A 20 year journey after discovery of the complete human PD-1 gene
Kristin Nicole Berger et al.
GENE (2018)
Cross-Cohort Analysis Identifies a TEAD4-MYCN Positive Feedback Loop as the Core Regulatory Element of High-Risk Neuroblastoma
Presha Rajbhandari et al.
CANCER DISCOVERY (2018)
Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas
Franz X. Schaub et al.
CELL SYSTEMS (2018)
OmoMYC blunts promoter invasion by oncogenic MYC to inhibit gene expression characteristic of MYC-dependent tumors
L. A. Jung et al.
ONCOGENE (2017)
Biophysical characterization of the b-HLH-LZ of ΔMax, an alternatively spliced isoform of Max found in tumor cells: Towards the validation of a tumor suppressor role for the Max homodimers
Loika Maltais et al.
PLOS ONE (2017)
Cell-Penetrating Peptides: From Basic Research to Clinics
Giulia Guidotti et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2017)
MYC Deregulation in Primary Human Cancers
Manpreet Kalkat et al.
GENES (2017)
Strategies to Inhibit Myc and Their Clinical Applicability
Jonathan R. Whitfield et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2017)
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
Padmanee Sharma et al.
CELL (2017)
MYC regulates the antitumor immune response through CD47 and PD-L1
Stephanie C. Casey et al.
SCIENCE (2016)
Growth suppression by MYC inhibition in small cell lung cancer cells with TP53 and RB1 inactivation
Francesco Paolo Fiorentino et al.
ONCOTARGET (2016)
c-Myc targeted regulators of cell metabolism in a transgenic mouse model of papillary lung adenocarcinoma
Yari Ciribilli et al.
ONCOTARGET (2016)
Small-molecule inhibitors of the Myc oncoprotein
Steven Fletcher et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2015)
c-MYC Copy-Number Gain Is an Independent Prognostic Factor in Patients with Colorectal Cancer
Kyu Sang Lee et al.
PLOS ONE (2015)
MYC: connecting selective transcriptional control to global RNA production
Theresia R. Kress et al.
NATURE REVIEWS CANCER (2015)
Myc inhibition is effective against glioma and reveals a role for Myc in proficient mitosis
Daniela Annibali et al.
NATURE COMMUNICATIONS (2014)
Therapeutic Strategies to Inhibit MYC
Michael R. McKeown et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2014)
An Overview of MYC and Its Interactome
Maralice Conacci-Sorrell et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2014)
Efficacy of BET Bromodomain Inhibition in Kras-Mutant Non-Small Cell Lung Cancer
Takeshi Shimamura et al.
CLINICAL CANCER RESEARCH (2013)
Inhibition of Myc family proteins eradicates KRas-driven lung cancer in mice
Laura Soucek et al.
GENES & DEVELOPMENT (2013)
MYC-y mice: From tumour initiation to therapeutic targeting of endogenous MYC
Jennifer P. Morton et al.
MOLECULAR ONCOLOGY (2013)
Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells
Cosimo Commisso et al.
NATURE (2013)
ATF4 Regulates MYC-Mediated Neuroblastoma Cell Death upon Glutamine Deprivation
Guoliang Qing et al.
CANCER CELL (2012)
Tumor microenvironment: becoming sick of Myc
Jonathan R. Whitfield et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2012)
siRNA and pharmacological inhibition of endocytic pathways to characterize the differential role of macropinocytosis and the actin cytoskeleton on cellular uptake of dextran and cationic cell penetrating peptides octaarginine (R8) and HIV-Tat
M. Al Soraj et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Cell entry of cell penetrating peptides: tales of tails wagging dogs
Arwyn T. Jones et al.
JOURNAL OF CONTROLLED RELEASE (2012)
The Max b-HLH-LZ Can Transduce into Cells and Inhibit c-Myc Transcriptional Activities
Martin Montagne et al.
PLOS ONE (2012)
Cell-penetrating peptides: breaking through to the other side
Erez Koren et al.
TRENDS IN MOLECULAR MEDICINE (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
MYC Amplification as a Prognostic Marker of Early-Stage Lung Adenocarcinoma Identified by Whole Genome Copy Number Analysis
Reika Iwakawa et al.
CLINICAL CANCER RESEARCH (2011)
Endogenous Myc maintains the tumor microenvironment
Nicole M. Sodir et al.
GENES & DEVELOPMENT (2011)
The Action Mechanism of the Myc Inhibitor Termed Omomyc May Give Clues on How to Target Myc for Cancer Therapy
Mauro Savino et al.
PLOS ONE (2011)
c-Myc Regulates Transcriptional Pause Release
Peter B. Rahl et al.
CELL (2010)
MYC regulation of a poor-prognosis metastatic cancer cell state
Anita Wolfer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
The Max homodimeric b-HLH-LZ significantly interferes with the specific heterodimerization between the c-Myc and Max b-HLH-LZ in absence of DNA: a quantitative analysis
Francois-Olivier McDuff et al.
JOURNAL OF MOLECULAR RECOGNITION (2009)
MYC and EIF3H Coamplification Significantly Improve Response and Survival of Non-small Cell Lung Cancer Patients (NSCLC) Treated with Gefitinib
Federico Cappuzzo et al.
JOURNAL OF THORACIC ONCOLOGY (2009)
Emerging roles of E2Fs in cancer: an exit from cell cycle control
Hui-Zi Chen et al.
NATURE REVIEWS CANCER (2009)
Cell penetrating peptide-modified pharmaceutical nanocarriers for intracellular drug and gene delivery
Vladimir P. Torchilin
BIOPOLYMERS (2008)
Modelling Myc inhibition as a cancer therapy
Laura Soucek et al.
NATURE (2008)
N-myc augments death and attenuates protective effects of Bcl-2 in trophically stressed neuroblastoma cells
A. Ushmorov et al.
ONCOGENE (2008)
MYC - TIMELINE Reflecting on 25 years with MYC
Natalie Meyer et al.
NATURE REVIEWS CANCER (2008)
Cell-penetrating peptides for drug delivery across membrane barriers
Camilla Foged et al.
EXPERT OPINION ON DRUG DELIVERY (2008)
Conditional transgenic models define how MYC initiates and maintains tumorigenesis
Constadina Arvanitis et al.
SEMINARS IN CANCER BIOLOGY (2006)
BETA2/NeuroD protein can be transduced into cells due to an arginine- and lysine-rich sequence
H Noguchi et al.
DIABETES (2005)
The NMR solution structure of a mutant of the max b/HLH/LZ free of DNA:: Insights into the specific and reversible DNA binding mechanism of dimeric transcription factors
S Sauvé et al.
JOURNAL OF MOLECULAR BIOLOGY (2004)
Omomyc expression in skin prevents Myc-induced papillomatosis
L Soucek et al.
CELL DEATH AND DIFFERENTIATION (2004)
Defining the temporal requirements for Myc in the progression and maintenance of skin neoplasia
I Flores et al.
ONCOGENE (2004)
Identification of novel Myc target genes with a potential role in lymphomagenesis
D Marinkovic et al.
NUCLEIC ACIDS RESEARCH (2004)
Improving the thermodynamic stability of the leucine zipper of max increases the stability of its b-HLH-LZ:E-box complex
N Jean-François et al.
JOURNAL OF MOLECULAR BIOLOGY (2003)
Sustained loss of a neoplastic phenotype by brief inactivation of MYC
M Jain et al.
SCIENCE (2002)
Suppression of Myc-induced apoptosis in β cells exposes multiple oncogenic properties of Myc and triggers carcinogenic progression
S Pelengaris et al.
CELL (2002)
Distribution of intranasal instillations in mice: effects of volume, time, body position, and anesthesia
DS Southam et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2002)
Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras
EL Jackson et al.
GENES & DEVELOPMENT (2001)
N-myc enhances the expression of a large set of genes functioning in ribosome biogenesis and protein synthesis
K Boon et al.
EMBO JOURNAL (2001)
Share Paper
